🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
4.880
-0.200 (-3.94%)
Nov 20, 2026, 3:00 PM CST

SHA:600223 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
157.04187.75243.53303.3945.46361.9
Depreciation & Amortization
108.6108.6102.23147.76121.694.03
Other Amortization
15.3715.3711.0810.018.017.91
Loss (Gain) From Sale of Assets
0.060.06-0.960.77-0.770.15
Asset Writedown & Restructuring Costs
0.170.170.72.194.744.04
Loss (Gain) From Sale of Investments
-55.39-55.39-63.98-214.34-116.21-201.34
Provision & Write-off of Bad Debts
10.2710.2725.9438.3166.86101.05
Other Operating Activities
94.3459.9182.83162.9684.2335.79
Change in Accounts Receivable
-87.79-87.79175.891,861523.122,032
Change in Inventory
119.35119.35-33.91-598.861,899344.74
Change in Accounts Payable
-80.34-80.34-308.12-1,228-2,2383,760
Change in Other Net Operating Assets
-----5.59
Operating Cash Flow
279.95276.22228.65474.15998.16,848
Operating Cash Flow Growth
35.94%20.80%-51.78%-52.49%-85.42%53.96%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-99.23-110.42-157.22-211.37-166.11-281.53
Sale of Property, Plant & Equipment
0.20.080.333.895.70.61
Divestitures
-6.73-11.262,9822,641-33.05
Investment in Securities
1.860.0611.68177.5230.83-268.32
Other Investing Activities
55.562.15155.8562.69130.8164.38
Investing Cash Flow
-48.39-59.382,9932,6731.24-451.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-296.323482,70112,6219,931
Total Debt Issued
157.61296.323482,70112,6219,931
Long-Term Debt Repaid
--457.35-2,235-5,281-13,161-15,351
Lease Payments
-8.4-8.4----
Total Debt Repaid
-290.85-457.35-2,235-5,281-13,161-15,351
Net Debt Issued (Repaid)
-133.24-161.03-1,887-2,580-540.61-5,420
Issuance of Common Stock
----22.4717.05
Common Dividends Paid
-60.28-65.19-183.57-487.96-1,175-2,015
Other Financing Activities
-10.77-20.94-35.02-29.6975.44629.44
Financing Cash Flow
-204.29-247.16-2,106-3,097-1,618-6,789

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.22-0.01-0.23-1.019.82-0.41
Net Cash Flow
27.04-30.331,11648.93-608.61-393.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
180.72165.871.44262.79831.986,567
Free Cash Flow Growth
129.75%132.10%-72.82%-68.41%-87.33%53.04%
Free Cash Flow Margin
4.72%4.54%1.79%5.74%6.42%53.12%
Free Cash Flow Per Share
0.170.160.070.260.736.35
Levered Free Cash Flow
109.5573.023,1062,8791,8372,779
Unlevered Free Cash Flow
112.1276.673,1202,9392,0882,849
Free Cash Flow After Leases
172.32157.471.44262.79831.986,567

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.171.17----
Cash Income Tax Paid
290.97277.93290.52553.181,0991,786
Change in Working Capital
-50.53-50.53-172.7123.18184.26,145